Amoxicillin
Brand names: Amoxil
Amoxicillin is a broad-spectrum aminopenicillin antibiotic for respiratory, ENT, urinary and other infections, and part of Helicobacter pylori regimens.
Adult dose
Paediatric dose
Dose adjustments
In renal impairment the dose should be adjusted according to the degree of impairment (see SPC §4.2 renal impairment table; full table truncated in source).
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Children weighing < 40 kg. Most indications (acute bacterial sinusitis, acute otitis media, community acquired pneumonia, acute cystitis, acute pyelonephritis, dental abscess with spreading cellulitis): 20 to 90 mg/kg/day in divided doses. Acute streptococcal tonsillitis and pharyngitis: 40 to 90 mg/kg/day in divided doses. Typhoid and paratyphoid fever: 100 mg/kg/day in three divided doses. Twice-daily dosing regimens should only be considered when the dose is in the upper range. Paediatric Suspension is recommended for children under six months of age. Verify against a children's formulary.
US labelling (FDA)
Reference — US labelling, may differ from UKAdults and Pediatric Patients greater than 40 kg: 500 or 875 mg every 12 hours or 250 or 500 mg every 8 hours, based on the amoxicillin component. ( 2.2 , 2.3 ) Pediatric patients aged 12 weeks (3 months) and older: 25 to 45 mg/kg/day every 12 hours or 20 to 40 mg/kg/day every 8 hours, up to the adult dose. ( 2.3 ) Neonates and infants less than 12 weeks of age: 30 mg/kg/day divided every 12 hours, based on the amoxicillin component. Use of the 125 mg/5 mL oral suspension is recommended. ( 2.3 ) 2.1 Important Administration Instructions Amoxicillin and Clavulanate Potassium may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when Amoxicillin and …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2024-04-30. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Contraindications
- Hypersensitivity to amoxicillin, to any of the penicillins, or to any excipient
- History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam)
Side effects
- Diarrhoea
- Nausea
- Skin rash
- Vomiting (uncommon)
- Urticaria and pruritus (uncommon)
Interactions
- Probenecid: decreases renal tubular secretion of amoxicillin; co-administration not recommended
- Oral anticoagulants: may prolong prothrombin time (raised INR); monitor
- Allopurinol: increases the risk of rash
- Oral contraceptives: efficacy may be reduced
Clinical monograph
How it works
A beta-lactam that inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins.
Prescribing in practice
- Avoid in penicillin allergy.
- It commonly causes a non-allergic rash if given during glandular fever (infectious mononucleosis).
- Like other antibiotics it can predispose to Clostridioides difficile and, rarely, hypersensitivity.
Monitoring
Short courses need no routine monitoring; review the response.
Counselling the patient
- Complete the course.
- Report a rash, wheeze or facial swelling (possible allergy).
- Report severe or prolonged diarrhoea.
Evidence & guidelines
A first-line antibiotic for many community infections (NICE/local antimicrobial guidance).
Reference: NICE NG120 UTIs; PHE UECAP guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- MAGGIC Heart Failure Risk Score · Heart Failure
- Long QT Syndrome (Schwartz Score) · Channelopathy / Sudden Cardiac Death
- C-Peptide to Glucose Ratio · Diabetes Classification
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Acute Otitis Media Severity (AOM-SOS) · Otitis Media
- International Staging System (ISS) for Multiple Myeloma · Multiple Myeloma
- Infective Endocarditis · ESC 2023 Infective Endocarditis Guidelines; NICE NG41
- Eczema Herpeticum · BAD; NICE CKS
- Suspected Bacterial Meningitis (Adult) · NICE NG240 (2024); NICE NG143 (paeds)
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021
- Returning Traveller — Fever · NaTHNaC; PHE; ESCMID 2018
- Malaria — Diagnosis & Management · PHE 2016; WHO 2023